Equity

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Balaxi Pharmaceuticals LtdIndustry : Trading
BSE Code:532597 NSE Symbol: BALAXI P/E (TTM) :79.88
ISIN Demat:INE618N01014 Div & Yield %:0 EPS (TTM) :7.5
Book Value (RS) :117.0934413 Market Cap (Rs Cr.):652.88 Face Value (RS) :10
    Change Company 
Particulars Quarter Ended
(Dec 2023)
Quarter Ended
(Dec 2022)
Quarter Ended
(% Var)
Sales 12.70 23.07 -44.95
Other Income 1.03 1.34 -23.13
PBIDT 1.31 4.91 -73.32
Interest 0.41 0.01 4,000.00
PBDT 0.90 4.90 -81.63
Depreciation 0.13 0.08 62.50
PBT 0.77 4.82 -84.02
Tax 0.31 1.28 -75.78
Deferred Tax -0.03 0.00 0.00
PAT 0.49 3.53 -86.12

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)